November 15, 2011
According to IMS Japan, Japan’s ethical drug market showed steady growth in July-September 2011, up 7.7% from a year earlier at ¥2,332.257 billion on an NHI price basis. The lack of an NHI price revision prompted consecutive growth for three...read more